255 related articles for article (PubMed ID: 8289984)
1. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
Nephron; 1993; 65(3):359-63. PubMed ID: 8289984
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.
Mindikoglu AL; Dowling TC; Wong-You-Cheong JJ; Christenson RH; Magder LS; Hutson WR; Seliger SL; Weir MR
Am J Nephrol; 2014; 39(6):543-52. PubMed ID: 24943131
[TBL] [Abstract][Full Text] [Related]
4. Increased cerebrovascular resistance in cirrhotic patients with ascites.
Guevara M; Bru C; Ginès P; Fernández-Esparrach G; Sort P; Bataller R; Jiménez W; Arroyo V; Rodés
Hepatology; 1998 Jul; 28(1):39-44. PubMed ID: 9657094
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
[TBL] [Abstract][Full Text] [Related]
6. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.
Pariente EA; Bataille C; Bercoff E; Lebrec D
Gastroenterology; 1985 May; 88(5 Pt 1):1255-9. PubMed ID: 3884428
[TBL] [Abstract][Full Text] [Related]
8. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
9. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
10. [Physiopathology of nephropathy in liver cirrhosis. Pathogenetic role of ascites and of inferior vena cava pressure increase].
Gatta A; Zuin R; Merkel C; Milani L; Ruol A
Minerva Dietol Gastroenterol; 1979; 25(1):9-16. PubMed ID: 450267
[No Abstract] [Full Text] [Related]
11. [Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis].
Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D
Gastroenterol Clin Biol; 1989; 13(8-9):701-6. PubMed ID: 2680727
[TBL] [Abstract][Full Text] [Related]
12. Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
Woitas RP; Flommersfeld S; Stoffel-Wagner B; Schiedermaier P; Brensing KA; Spengler U; Sauerbruch T
Scand J Gastroenterol; 2002 Nov; 37(11):1321-7. PubMed ID: 12465732
[TBL] [Abstract][Full Text] [Related]
13. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
Kimer N; Pedersen JS; Busk TM; Gluud LL; Hobolth L; Krag A; Møller S; Bendtsen F;
Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
[TBL] [Abstract][Full Text] [Related]
14. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
MacGilchrist A; Craig KJ; Hayes PC; Cumming AD
Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142
[TBL] [Abstract][Full Text] [Related]
15. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.
Krag A; Bendtsen F; Henriksen JH; Møller S
Gut; 2010 Jan; 59(1):105-10. PubMed ID: 19837678
[TBL] [Abstract][Full Text] [Related]
16. Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.
Colle I; Moreau R; Pessione F; Rassiat E; Heller J; Chagneau C; Pateron D; Barrière E; Condat B; Sogni P; Valla D; Lebrec D
Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):251-6. PubMed ID: 11293444
[TBL] [Abstract][Full Text] [Related]
17. Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure.
Moreau R; Pussard E; Brenard R; Gaudin C; Berdeaux A; Lebrec D
J Hepatol; 1991 Nov; 13(3):351-7. PubMed ID: 1839683
[TBL] [Abstract][Full Text] [Related]
18. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
20. Renal haemodynamics in patients with liver cirrhosis assessed by colour ultrasonography.
Wang Y; Liu LP; Bai WY; Wen SB; Dan HJ; Luan YY; Zeng MX; Hu B
J Int Med Res; 2011; 39(1):249-55. PubMed ID: 21672328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
